Introduction

Clinical programmes have been set up to improve patient flow and optimise capacity use within Irish hospitals. Despite the need to reduce avoidable bed use and release much needed bed capacity, the potential impact of reducing disease related malnutrition (DRM)  has not been examined.

Although largely preventable if detected early, DRM is a significant cause of excess morbidity and mortality in older and chronically ill patients and a major burden on healthcare systems. Due to delayed recovery and higher complication rates, poorly nourished patients have more frequent GP and outpatient visits, up to twice as many hospital admissions and longer and more complicated hospital episodes^1-4. It is estimated that at any time in Ireland, DRM affects approximately 140,000 adults with associated annual care costs exceeding €1.4billion⁵, mostly arising in acute care settings. This is despite the fact that the vast majority of malnutrition exists in the community¹ where the potential for its prevention and treatment is greatest.

Oral Nutrition Supplements (ONS) are designed to prevent and treat undernutrition. Evidence of their efficacy is underpinned by expert clinical guidelines including those of the National Institute for Clinical Excellence (NICE)⁶. There is increasing evidence of their cost effectiveness compared to standard care, arising largely from reductions in use of acute care resources.  For example, in an 11 year US study involving 44million patient episodes, ONS use significantly reduced hospital inpatient stay, episode costs and readmissions⁷. More recently, a systematic review and meta-analysis involving 19 publications (9 randomised controlled trials) found that multi-nutrient ONS use in undernourished community patients was associated with 16.5% fewer hospitalisations, delivering overall net cost savings⁸.

This paper applies the main meta-analysis outcome, reduced hospitalisation rate, to Irish inpatient activity and malnutrition prevalence survey data to examine the potential for targeted ONS use to reduce excess hospital admissions and acute bed day use in those treated.

Methods

The analysis was conducted in three steps. The first step established the proportion of inpatients aged 18-64 and >65 years who were malnourished (defined as medium + high risk using MUST criteria⁹). To do this, prevalence data from two national malnutrition screening surveys conducted in 2010 and 2011^10,11 were applied to relevant inpatient data (defined as inpatient discharges) from the Hospital Inpatient Enquiry system (HIPE) for the full year 2013, which was the latest available data at the time of preparation¹². To account for variations in prevalence rates by season and across different hospitals over the two years surveyed, higher and lower values (+/-10%) were applied. The second step calculated length of stay (LOS) and annual bed day use for malnourished patients, based on an estimated 30% longer LOS¹. Accordingly, LOS for those with and without malnutrition were calculated using the following equation:  Mean LOS (total no. days) = (% prevalence low risk)y + ^[1]% prevalence medium + high risk) x 1.3y), where y = LOS for low risk patients and 1.3y = LOS for medium and high risk patients, as per Elia et al (2009)1. The third step involved applying the … Continue reading. In all instances, greater benefit was observed from early use of ONS in older patients.

Discussion

This analysis shows that malnourished adults, using MUST criteria, use an estimated 36% of all adult acute hospital inpatient bed days in Ireland. Furthermore, it suggests that targeted use of ONS in the community has the potential to release 168,000 adult bed days per year based on available data, equivalent to 460 beds. This is important given that acute bed shortages in 2015 resulted in daily averages of 254 patients on trolleys despite bed occupancy rates reaching 92% of capacity versus recommended maximum levels of 85%^13.14.

Although clinically relevant malnutrition affects approximately 4% of the adult population at any time, its high prevalence (30%) and severity (75% high risk, 25% moderate risk scores) ^10,11 in patients admitted to Irish hospitals indicates a failure to identify and treat these patients appropriately in primary care settings, with major clinical and cost implications. This is perhaps unsurprising given the lack of systems and dietetic resources to ensure its early detection and appropriate treatment at primary care level¹⁵.  Currently routine screening initiatives are confined to residential care, with any primary care screening programmes regional in nature¹⁵. Given that around 92% of malnourished patients identified in Irish hospital are admitted from their own home,^10,11 improvements in screening and recognition of such patients by primary care providers are warranted.

The current analysis suggests that earlier, appropriately targeted ONS intervention used in accordance with best practice and with the intention of preventing malnutrition and its sequelae could release ≥ 4% of total acute bed days for other patients. This is significant with respect to both cost and bed occupancy rates.  In 2011, the average base costs for an acute inpatient bed day and an inpatient episode in an Irish hospital were €825 and €4580 respectively (Casemix, personal communication). Given that malnourished patients have longer LOS and higher episode costs, any reduction in hospitalisation and release of acute inpatient bed days has the potential for significant net savings and improved efficiencies in an overburdened system.   

It has been argued that ONS are overprescribed by GPs¹⁶ although expert opinion from hospital specialist dietitians estimates that fewer than 15% of malnourished patients identified on admission to hospital from primary care settings are already receiving appropriate nutritional support.  Although no published statistics exist regarding current ONS use in Ireland, total ONS expenditure (including paediatric products, thickeners and modular supplements) under community funded schemes was publicly reported to be approximately €30million in 2013. Based on IMS data regarding the proportion of expenditure that relates to adult multi-nutrient products and expert opinion regarding the average number of units prescribed per day across all adult patients, we estimate that between 17,000 and 20,000 adult community based patients are receiving ONS at any time. Whilst this is not an insignificant number, it represents around 1 in 7 of the estimated 140 000 adults with DRM nationally at any time.

This paper describes the potential benefits of earlier intervention aimed at prevention of malnutrition in community patients as a means of reducing hospitalisation. Strengths include the use of nationally published prevalence and hospital inpatient activity data and the inclusion of a two-way sensitivity analysis with respect to malnutrition prevalence and ONS use. Limitations acknowledged include the low-moderate (16%) heterogeneity of the studies included in the systematic review by Elia et al (2016), the lack of detailed data on ONS use and prescribing practices in Ireland and the retrospective application of national prevalence data obtained in 2010 and 2011 to HIPE inpatient data for 2013. The decision to apply national survey data retrospectively to the latest available inpatient data was considered to provide the most reliable assessment of the impact of malnutrition or its reduction on current and future bed capacity.

In summary, more than one third of all Irish acute hospital bed days in 2013 are estimated to have involved malnourished patients. This analysis suggests that more effective systems for detection of nutritional risk via screening programmes coupled with evidence-based treatment pathways and dietetic input to ensure earlier targeted use of ONS in community patients has the potential to release much needed acute bed capacity back into the system, improving patient flow. Against a backdrop of chronic shortages in acute inpatient beds, the impact of DRM and the potential for improved outcomes and efficiency gains arising from its prevention merits further consideration and focused research.

Conflict of Interest

The authors confirm there is no conflict of interest with this study

 

Correspondence:

Anne Nugent BSc PhD RNutr  (Corresponding author), School of Agriculture and Food Science

UCD Institute of Food and Health, UCD, Belfield

Email: [email protected]

Phone: +087 986 4415

 

References:

1. Elia M, Russell CA. Combating malnutrition: recommendations for action. A report from the advisory group on malnutrition, led by BAPEN. 2009. London. Report No.: 978 1 899467 36 5, http://www.bapen.org.uk/professionals/publications-and-resources/bapen-reports /combating-malnutritionrecommendations-for-action.

2. Lim SL, Ong KC, Chan YH, Loke WC, Ferguson M, Daniels L. (2012). Malnutrition and its impact on cost of hospitalization, length of stay, readmission and 3-year mortality. Clin Nutr, 31(3), 345-350.

3. Sorensen J, Kondrup J, Prokopowicz J, Schiesser M, Krahenbuhl L, Meier R. EuroOOPS: an international, multicentre study to implement nutritional risk screening and evaluate clinical outcome. Clin Nutr 2008; 27(3):340-349.

4. Guest JF, Panca M, Baeyens JP, de Man F, Ljungqvist O, Pichard C, Wait S, Wilson L. (2011) 'Health economic impact of managing patients following a community-based diagnosis of malnutrition in the UK', Clinical Nutrition, 30 (4).

5. Rice N, Normand C. (2012) The cost associated with disease related malnutrition in Ireland. JPHN,15(10), 1966-1972.

6. National Institute for Health and Clinical Excellence (NICE). (2006).Nutrition Support in Adults: Oral Nutrition Support, Enteral Tube Feeding and Parenteral Nutrition. Clinical Guideline 3. https://www.nice.org.uk/guidance/cg32.

7. Philipson T.J., Snider J.T., Lakdawalla D.N., StryckmanB., Goldman, D.P.Impact of oral nutritional supplementation on hospital outcomes. Am J Manag Care. 2013;19:121–128

8. Elia M, Normand C, Laviano A, Norman K. (2016) A systematic review of the cost and cost effectiveness of using standard oral nutritional supplements in community and care home settings, Clinical Nutrition 35 (2016),125 – 137. http://dx.doi.org/10.1016/j.clnu.2015.07.012

9. Elia M, Screening for malnutrition: a multidisciplinary responsibility. Development and use of the ‘Malnutrition Universal Screening Tool’ (‘MUST’) for adults. MAG, a Standing Committee of BAPEN (ISBN 1 899467 70 X) 2003.

10. Russell CA, Elia. M., on behalf of BAPEN and collaborators (2010). Nutrition screening survey in the UK and Republic of Ireland in 2010. Retrieved 5^th March 2016.

11. Russell CA, Elia. M., on behalf of BAPEN and collaborators (2011). Nutrition screening survey in the UK and Republic of Ireland in 2011. Retrieved 5^th March 2016.

12. Activity in Acute Public Hospitals in Ireland 2013 Annual Report https://www.hpo.ie/latest_HIPE_nprs_reports/HIPE_2013/HIPE_Report_2013.pdf.

13.INMO Trolley and Ward Watch Annual Analysis 2006 – 2015 https://www.inmo.ie/Trolley_Ward_Watch

14. IHCA Pre-Budget Submission:2016. http://www.ihca.ie/_fileupload/IHCA%20Pre%20Budget%20Submission%202016%20FINAL.pdf

15.Kennelly S, Kennedy NP, Corish CA, Flanagan-Rughoobur G, Glennon-Slattery C. Sugrue S. (2011), Sustained benefits of a community dietetics intervention designed to improve oral nutritional supplement prescribing practices. Journal of Human Nutrition and Dietetics, 24: 496–504. doi: 10.1111/j.1365-277X.2011.01197.x

16. De Paor. Tackling overuse of nutritional supplements.  ICGP Forum; Quality in Practice, July 2010. https://www.icgp.ie/assets/99/A699EAD5-19B9-E185-833FC7EF48FC826A_document/Nutrition_12-13.pdf

 

p422